| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |